FinancialNewsMedia.com

FinancialNewsMedia.com
Professional News Dissemination Services

Tuesday, December 23, 2014

NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut

Apollo Robbins to Demonstrate How Easily Your Wallet is Stolen and How Wocket Protects You from Identity Theft 

SHELTON, Conn., - (http://www.financialnewsmedia.com News Alert) - NXT-ID, Inc. (NASDAQ:NXTD) and (NXTDW) ("NXT-ID" or the "Company"), a biometric authentication company focused on the growing mobile commerce market, announces it has retained famous pickpocket, entertainer and security consultant, Apollo Robbins for the 2015 International CES debut of the Wocket(TM) biometric smart wallet.

Apollo Robbins will be at the NXT-ID booth January 6th and 7th, 2015, demonstrating some of his famous theft techniques to visiting media and consumers. He will show the audience how easy it is to have their wallet stolen and ultimately their identity.

Gino Pereira, CEO of NXT-ID said, "An average of 13 Million people a year have their identity stolen and 44% of known causes can be traced to a stolen wallet or purse. The Wocket was designed to protect your identity by acting as your personal vault. It is only accessed by you through your personal voice biometric or PIN. Apollo seemed like the perfect fit to associate wallet theft and identity theft problems with our ultimate solution, the Wocket."

NXT-ID will showcase Wocket smart wallet at the 2015 International CES (Consumer Electronics Show) in Las Vegas, January 6-9, 2015 at booth 21926 in South Hall 1, lower level (LVCC). The Wocket can selectively be used at the booth by media and invited guests to make purchases of brand paraphernalia, demonstrating first-hand how convenient and secure the technology is.

Apollo Robbins is a performer, speaker, consultant and one of the world's leading experts on pickpockets, confidence crimes and deception. A pioneer in the application of deception to operational environments, Robbins uses pick-pocketing and sleight-of-hand to demonstrate perception management, diversion techniques and self-deception.

Known as "The Gentleman Thief," Robbins first made national news as the man who pick-pocketed the Secret Service while entertaining former U.S. president Jimmy Carter. He has picked the pockets of more than 250,000 men and women. Forbes has called him "an artful manipulator of awareness," and Wired Magazine has written that "he could steal the wallet of a man who knew he was going to have his pocket picked."

Robbins has been featured in the New Yorker and in numerous publications such as New York Times, Los Angeles Times, and The Wall Street Journal. He produced and co-hosted the National Geographic program Brain Games, which was nominated for an Emmy as an Outstanding Informational Series. His popular appearance on The Today Show is a YouTube favorite at more than 7 million views. The TED editors described Robbins's talk at TED Global 2013 as a revelation in the flaws of human perception. His latest project, a Warner Brothers film starring Will Smith, will open in international theatres starting February 2015.

Wocket is a smart wallet designed to protect your identity and replace all the cards in your wallet, with no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval.

Credit, debit, ATM, loyalty, gift, ID, membership, insurance, ticket, emergency, medical, business, contacts, coupon, and virtually any card can be protected on Wocket. More than 10,000 cards, records, coupons, etc. can also be stored on Wocket.

Wocket is currently available by requesting an invitation at www.wocketwallet.com

Watch the Video: "Experience the Wocket Smart Wallet at CES 2015"https://www.youtube.com/watch?v=W8GQ7faZt7o&feature=youtu.be

About NXT- ID Inc. - Mobile Security for a Mobile World: (NXTD) (NXTDW):

NXT-ID, Inc.'s innovative MobileBio solution mitigates consumer risks associated with mobile computing, m-commerce and smart OS-enabled devices. The company is focused on the growing m-commerce market, launching its innovative MobileBio suite of biometric solutions that secure consumers' mobile platforms led by Wocket(TM) ; a next generation smart wallet designed to replace all the cards in your wallet, no smart phone required. The Wocket works anywhere credit cards are accepted and only works with your biometric stamp of approval. http://www.wocketwallet.com/

NXT-ID' wholly owned subsidiary, 3D-ID LLC, is engaged in biometric identification and has 22 licensed patents in the field of 3D facial recognition http://www.nxt-id.com/, http://3d-id.net/

Forward-Looking Statements for NXT-ID: This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward-looking statements include statements herein with respect to the successful execution of the Company's business strategy. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Such risks and uncertainties include, among other things, our ability to establish and maintain the proprietary nature of our technology through the patent process, as well as our ability to possibly license from others patents and patent applications necessary to develop products; the availability of financing; the Company's ability to implement its long range business plan for various applications of its technology; the Company's ability to enter into agreements with any necessary marketing and/or distribution partners; the impact of competition, the obtaining and maintenance of any necessary regulatory clearances applicable to applications of the Company's technology; and management of growth and other risks and uncertainties that may be detailed from time to time in the Company's reports filed with the Securities and Exchange Commission.

Contact:

Corporate info: info@nxt-id.com

Media: 800 665-0411dvanzant@investorideas.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/nxt-id-hires-master-pickpocket-and-security-consultant-apollo-robbins-for-wocket-smart-wallet-ces-2015-debut-300012953.html

SOURCE NXT-ID, Inc.


FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated one thousand four hundred dollars for news coverage of the current press release issued by NXT-Id, Inc. by the company.

 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Wednesday, October 22, 2014

OSL Holdings Announces the Acquisition of Go Green Hydroponics

YARDLEY, Pa., - (http://www.financialnewsmedia.com News Alert) - OSL Holdings, Inc. (OTCQB: OSLH) ("OSL" or "the Company"), a socially conscious business model dedicated to consumer advocacy, social activism and the advancement of civil liberties through the power of commerce, announced today the acquisition of Go Green Hydroponics, Inc. ("Go Green Hydroponics") a privately held hydroponics, indoor gardening and cultivation supply retail operation, located in Los Angeles, California, specializing in the sale of hydroponic cultivation equipment, mineral nutrient solutions and gardening resources and equipment. Go Green Hydroponics achieved revenues of approximately $2.4 million in the first nine months of 2014 and is expected to reach revenues of approximately $3.0 million in fiscal 2014 with expected future annual revenue increases at a rate of 10% to 15% with expected gross profit margins of approximately 25% to 30%.

OSL acquired Go Green Hydroponics for $1.8 million subject to certain post closing adjustments based on a target working capital amount. OSL also closed on a debt financing transaction in the amount of $1.9 million, the proceeds of which were used to fund the Go Green Hydroponics acquisition and for OSL working capital.

Bob Rothenberg, OSL's Chief Executive Officer said, "We are very excited about the acquisition of Go Green Hydroponics. Go Green is one of the most highly regarded brands in the vertical, continues to be a profitable business enjoying tremendous growth in the Los Angeles market."  Steve Gormley, OSL's Chief Business Development Officer said,  "This acquisition advances OSL's mission and commitment to our Medical Services Division. OSL continues to support civil liberties through the power of commerce."


OSL Medical Services is a management, future planning and services platform centered on the development and financing of indoor gardens and cultivation facilities, production technologies, merchandise and operational services for businesses in the herbal and natural medicine industry.  OSL Medical Services is designed to support its clients with branding, technology, marketing, logistics, and future planning services on a state-by-state basis throughout the United States.

OSL Medical Services provides these support services in compliance with all federal, state and local laws. At this time, OSL will not grow or sell marijuana, but intends to gain market share and create value for its shareholders by creating, marketing, and licensing brands as well as acquiring and licensing production technology. When federal law permits, OSL Medical Services expects to provide these services to legal and licensed growers and dispensers. 

The hydroponic food production industry is expanding at a rate that is set to outpace the 2014 IMF estimate of global growth by 80%. Hydroponics systems are being deployed to grow key vegetable and fruit crops at scale, driving the transition to safe and sustainable food production worldwide. Agriculture is traditionally a conservative market sector, but the benefits of higher yields with lower inputs, improved soil and water quality, and food safety are compelling forces for change.

The worldwide market value of hydroponically produced food is expected to show sustained strength with a 6.5% compound annual growth rate (CAGR) over the five-year forecast period 2013-2018, beating the IMF estimated growth forecast of 3.6% for 2014. Producer value will increase from $17.7 billion to $24.3 billion. Growth is expected to be steady thanks to the buffering effect of mature European markets, with expected acceleration over the period due to emerging growth in North America and Eastern Europe.

It is estimated that legal medical marijuana cultivators spend $400 million a year on hydroponic gardening, nutrient, equipment and resources supplies in the United States alone.

http://www.gogreenhydrostore.com

About OSL

OSL Holdings, Inc. (OTC: OSLH) is a development and technology company specializing in affluent, liberal markets with high disposal income.  The Company intends to operate a real-time loyalty rewards platform that can facilitate the earning and redemption of rewards currency at the point of the transaction (online, mobile, at retail) as well as on future transactions.  OSL Holdings' target consumers are highly educated, respond to cause marketing initiatives and socially conscious business models, and are technologically savvy.  On March 10, 2014, the Company announced its intent to enter the legal marijuana market when federal law permits, providing foundational work for branding, marketing, technology, and logistics to existing or emerging legal marijuana licensees.

The Company's filings with the SEC are available at http://www.sec.gov/cgi-bin/browse-edgar?company=osl+holdings&owner=exclude&action=getcompany.

For more information, please visit the Company's website at http://www.oslholdings.com.

Forward Looking Statements -- Safe Harbor

This press release contains forward-looking statements as defined in the United States Private Securities Litigation Reform Act of 1995.  In some cases you can identify those so-called "forward looking statements" by words such as "may," "will," "should," "expects," plans," "targets," "believes," "anticipates," "estimates," "predicts," "potential," or "continue" or the negative of those words and other comparable words.  These statements include, but are not limited to, our expectations concerning Go Green's revenue growth, growth rates for hydroponically produced food, the market for medical marijuana cultivators, and our ability to provide support services to marijuana growers.

By their nature, forward-looking statements and forecasts involve risks and uncertainties because they relate to events and depend on circumstances that will occur in the future.  There are a number of factors, risks and uncertainties that could cause actual results and developments to differ materially from forecasted results.  For a discussion of these factors, risks and uncertainties please see our filings with the Securities and Exchange Commission.  Our public filings with the Commission are available from commercial document retrieval services and at the website maintained by the Securities and Exchange Commission at http://www.sec.gov.  We assume no obligation to update or alter our forward-looking statements made in this release or in any periodic report filed by us under the Securities Exchange Act of 1934 or any other document, whether as a result of new information, future events or otherwise, except as otherwise required by applicable federal securities laws.

Company Contact:

OSL Holdings Inc.
IR/Media Contact:
Craig S. Fischer
Communications Manager
O) +1-786-375-0556

Strategic Tactical Asset Trading LLC
1926 Hollywood Blvd
Suite 209
Hollywood,  FL 33020
info@OSLHoldings.com
http://www.OSLHoldings.com
Website: http://www.oslholdings.com

SOURCE OSL Holdings Inc.

FN Media Group LLC (FNMG) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNMG was compensated one thousand seven hundred dollars for  OSL Holdings Inc.  news coverage by the company.  FNMG HOLDS NO SHARES OF  OSL Holdings Inc. 

 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Tuesday, October 14, 2014

RiceBran Technologies Sets Plant Expansion at Healthy Natural to Support Nutricosmetics and Personal Care Products

Company sees significant near-term opportunities for newly developed line of rice bran-based cosmetics

SCOTTSDALE, Ariz., - (http://www.FinancialNewsMedia.com News Alert) - RiceBran Technologies (NASDAQ: RIBT and RIBTW) (the "Company" or "RBT"), a global leader in the production and marketing of value added products derived from rice bran, today announced an additional expansion at its Healthy Natural, Inc. plant in Irving, Texas. This second expansion will install capacity for the expanded production of nutricosmetics and personal care products.

As announced in September 2014, the Company completed development of a series of rice bran-based products targeting the nutricosmetics and personal care markets. The expansion project will start in Q4 2014 and is expected to be completed before the end of Q2 2015.

RiceBran Technologies completed the first expansion project to more than double powdered beverage production capacity at Healthy Natural in July 2014. That expansion increased Healthy Natural's manufacturing footprint to more than 45,000 square feet with a monthly capacity to produce up to 400,000 canisters and gusseted bags. Additionally, the expansion allows for monthly output of up to 3 million single serve powdered beverage bottles.

Senior Vice President of contract manufacturing Mark McKnight commented "With the completion of the first stage expansion at our Irving, Texas manufacturing facility this past July, we are poised to take further advantage of the continued increase in demand for our non-GMO, gluten free, all natural, and minimally processed products. In addition, we are now embarking on a second expansion at Healthy Natural focused on nutricosmetics, a new and rapidly growing area of the cosmetics market and personal care industry. Rice bran is rich in nutrients and has applications across multiple finished goods vertical markets. We are working diligently to build these verticals into strong drivers of growth for our Company for years to come."

About RiceBran Technologies

RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products. Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutraceutical supplement manufacturers and retailers, both domestically and internationally. More information can be found in our filings with the SEC and by visiting our website at www.ricebrantech.com.

Forward-Looking Statements

This release contains forward-looking statements, including, but not limited to, statements about RiceBran Technologies' expectations regarding sales its sales, expanded production capacity, revenue and growth of nutricosmetics and personal care products through its Healthy Natural, Inc. subsidiary's expanded facilities. These statements are made based upon current expectations that are subject to known and unknown risks and uncertainties. RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies' filings with the Securities and Exchange Commission, including its most recent periodic reports.

Investor Contact

Ascendant Partners, LLCFred Sommer+1-732-410-9810fred@ascendantpartnersllc.com

SOURCE RiceBran Technologies

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For recent services performed FNMG has been compensated one thousand six hundred dollars for RiceBran Technologies news coverage by the Company.  FNMG HOLDS NO SHARES OF RiceBran Technologies.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Monday, October 6, 2014

Accelerize's Credit Facility from Square 1 Bank Expanded to $6 Million

Company intends to use increased financial flexibility to fuel strategic growth plan including expansion of its CAKE software platform into the digital advertising industry

NEWPORT BEACH, Calif., - (http://www.financialnewsmedia.com News Alert) - Accelerize New Media, Inc. (OTCBB: ACLZ), a leader in marketing technology solutions, and Square 1 Bank (Nasdaq: SQBK), the premier banking partner to entrepreneurs and the venture capital community, today announced an increase in Accelerize's credit facility from $3 million to $6 million to drive additional global adoption of its technology solutions into new and existing digital advertising markets.

The facility will be used primarily to build market awareness and increase sales for Accelerize's newly launched product, CAKE for Advertisers, a software solution developed by CAKE, its digital software division. Expanding the company's product offerings into a new market of large, brand advertisers, CAKE for Advertisers is specifically designed to unlock the value of real-time insights for digital marketers. eMarketer estimates that digital ad spending will total  $140.15 billion in 2014, accounting for approximately one quarter of all paid media spending worldwide. The new SaaS-based product is built to maximize effectiveness for advertisers by unifying the tracking, attribution and optimization of all digital marketing spend across search, display, email, video, social, affiliate and other channels.

In addition to CAKE for Advertisers, Accelerize intends to use the credit facility to roll out the recently enhanced version of its affiliate marketing software solution, CAKE for Networks. The product release provides new industry-leading capabilities for the company's base of over 450 customers. The organization also plans to develop additional SaaS-based software products based on the CAKE platform to broaden its market opportunities.

"Over the past several years we have established our high-growth company as a top provider of performance-based marketing software," said Brian Ross, CEO of Accelerize. "While we take great pride in this accomplishment, Accelerize now has the opportunity to extend our proven, recurring-revenue model to the ad tech industry with the introduction of CAKE for Advertisers. Plus, the additional capital from our trusted financial services partner, Square 1 Bank, makes us well positioned to embark on Accelerize's next chapter of expansion and deliver world-class solutions for brand advertisers and affiliate marketers.

Chris Erro, senior vice president at Square 1 Bank, added, "We are pleased to provide Accelerize with the additional working capital the company needs to execute on its strategy to move upstream with its growing enterprise product portfolio. We are always pleased to partner with a company that shares our commitment to creating innovative, market-leading solutions, and we look forward to continuing our support as the company migrates into these vast market opportunities."

About Square 1 Bank

Square 1 Bank is a full service commercial bank dedicated exclusively to serving the financial needs of the venture capital community and entrepreneurs in all stages of growth and expansion. Square 1's expertise, focus and strong capital base provide flexible resources and unmatched support to meet our clients' needs. Square 1 has offices coast-to-coast in Austin, the Bay Area,Boston, Denver, Durham, Los Angeles/Orange County, New York, San Diego, Seattle, and Washington, DC. For more information, visit www.square1bank.com.

About Accelerize

Accelerize New Media, Inc. (OTCQB: ACLZ) (OTCBB: ACLZ), offers marketing technology solutions that revolutionize the way advertisers leverage their digital advertising data. CAKE, a division of Accelerize, provides SaaS-based solutions that track, attribute and optimize the performance of digital marketing spend, in real-time. Bringing clarity to multi-channel marketing campaigns, CAKE empowers advertisers, agencies, publishers and networks with the insight to make intelligent marketing decisions. For more information on CAKE visit www.getCAKE.com.  For more information about Accelerize, visit www.accelerizenewmedia.com.

Use of Forward-looking Statements

This press release may contain forward-looking statements from Accelerize New Media, Inc. within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, when we describe our growth plan, when we say that the credit facility will be used to build market awareness and increase sales for CAKE for Advertisers, when we describe the estimated size of digital ad spending, when we say that we plan to develop additional products, and when we describe Accelerize as a high growth company,we are using forward-looking statements. These forward-looking statements are based on the current expectations of the management of Accelerize New Media only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. The following factors, among others, could cause actual results to differ materially from those described in the forward-looking statements: changes in technology and market requirements; our technology may not be validated as we progress further; we may be unable to retain or attract key employees whose knowledge is essential to the development of our products and services; unforeseen market and technological difficulties may develop with our products and services; inability to timely develop and introduce new technologies, products and applications; loss of market share and pressure on pricing resulting from competition, which could cause the actual results or performance of Accelerize New Media to differ materially from those contemplated in such forward-looking statements. Except as otherwise required by law, Accelerize New Media undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. For a more detailed description of the risk and uncertainties affecting Accelerize New Media, reference is made to Accelerize New Media's reports filed from time to time with the Securities and Exchange Commission.

Media Contact:

Jill Hara
PR@getCAKE.com
+1(949)548-2253 x 257

Investor Contact:
Ascendant Partners, LLC
Fred Sommer
fred@ascendantpartnersllc.com
+1(732) 410-9810

SOURCE Accelerize New Media Inc.

--------------------

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated one thousand five hundred fifty dollars for news coverage with regards to Accelerize New Media, Inc. by a non-affiliated third party.

 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Tuesday, September 30, 2014

Tapinator (TAPM) Reaches Milestone of 200,000 New Daily Players

NEW YORK, - (http://www.financialnewsmedia.com News Alert) - Tapinator, Inc. (OTC: TAPM) today announced that its games portfolio has reached the significant milestone of generating over 200,000 new players on a daily basis. This represents an all-time high for the Company in terms of daily new user volume.

These new players are derived from both the Company's recently launched games, such as Ambulance Rescue Simulator and Angry Shark Simulator, as well as the Company's older titles, including Transporter Plane 3D and Bus Driver 3D. Furthermore, the vast majority of these new players are acquired with zero marketing spend, by utilizing the Company's ability to successfully drive its titles up the app store leaderboards through cross promotion and search optimization strategies.

"Reaching 200,000 new daily players is a very significant milestone for us. We will enter Q4 with great new user numbers, and will be favorably positioned to take advantage of the holiday season's higher CPMs and advertising revenue potential," stated Tapinator CEO, Ilya Nikolayev.

To view Tapinator's portfolio, please navigate to the iOS, Google Play, or Amazon App Store and search for "Tapinator." Or, for a full listing of Tapinator games with links to each app store, please go to Tapinator.com.

About Tapinator:

Tapinator (OTC: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator's owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development offices in Pakistan, Denmark, and Indonesia. For a full listing of Tapinator game titles, please go to Tapinator.com. For further financial information on the Company, please go to OTCMarkets.com/stock/TAPM.  For live updates, please like us on Facebook at facebook.com/Tapinator or follow us on Twitter at twitter.com/Tapinator.

Forward Looking Statements:

To the extent that statements contained in this press release are not descriptions of historical facts regarding Tapinator, they are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will" "expect," "anticipate," "estimate," "intend," and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Examples of forward-looking statements contained in this press release include, among others, statements regarding the quoting and trading of our common stock and our expectations regarding our development and monetization plans for our mobile games. Forward-looking statements in this release involve substantial risks and uncertainties that could cause the development and monetization of our mobile games, future results, performance or achievements to differ significantly from those expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the uncertainties inherent in the hits nature of the mobile gaming business. Tapinator undertakes no obligation to update or revise any forward-looking statements. The quoting and trading of the company's common stock on the OTC Market Group's OTC Link quotation system is often thin and characterized by wide fluctuations in trading prices, due to many factors that may have little to do with the company's operations or business prospects. As a result, there may be volatility in the market price of the shares of the company's common stock for reasons unrelated to operating performance. Moreover, the OTC Market Group's OTC Link quotation system is not a stock exchange, and trading of securities on it is often more sporadic than trading of securities listed on the NASDAQ Stock market or another securities exchange. Accordingly, stockholders may have difficulty reselling any of their shares. For a further description of the risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of the company in general, see Tapinator's filings with the OTC Market Group, which are available through http://www.otcmarkets.com.

CONTACT:

Tapinator Investor Relations
investor.relations@tapinator.com
+1-914-930-6232

SOURCE Tapinator, Inc.

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which iis a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG was compensated one thousand seven hundred dollars for Tapinator, Inc. news coverage by the company.  FNMG HOLDS NO SHARES OF Tapinator, Inc.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Wednesday, September 24, 2014

ETST Announces Live CEO Interview and Recent Growth Progress as an Emerging Company Delivering Cutting Edge Nutraceuticals, Bioceuticals and Dietary Supplements for the Health, Wellness, Sports and Alternative Medicine Markets

BOCA RATON, FL, - (http://www.financialnewsmedia.com News Alert) - Earth Science Tech, Inc. (OTCQB: ETST) ("ETST" or "the Company"), a unique biotechnology company focused on nutraceuticals, bioceuticals and dietary supplements, announced today that its CEO, Harvey Katz PhD, as well as the company, was featured in a live video and article done by the Cannabis Financial Network. This new coverage and live CEO interview featured by Cannabis Financial Network outlines the recent success ETST has made in rapidly growing and expanding its business as an emerging company on many fronts. Some of the featured highlights from this live CEO video and article on ETST include:

-  ETST received two large bulk shipments of non-psychoactive, food-grade,
    CBD-enriched hemp oil, which is completely legal in 50 states and over
    40 countries worldwide (as per U.S. Hemp Foods specifications).
-  ETST already began selling; shipping its High Grade CBD Rich Hemp oil
    and an initial order to an outlet in Fort Lauderdale and its management
    is working hard to drum up additional supply lines.
-  ETST is moving towards widespread commercialization while setting
    themselves up to be a high-volume throughput channel for high-grade CBD.
-  ETST has already begun making their CBD products available online in
    half-ounce, ounce and two ounce bottles, and has made sizeable
    investments into their high-volume inventory model, with hundreds of
    thousands of dollars already outlaid and ambitions to fill persistent
    supply constraints in the CBD.
-  ETST funded assistant dean of the University of Central Oklahoma's
    College of Mathematics and Science, Wei R. Chen, Ph.D., with a $10k
    grant to study the anti-tumor effects of its ETST Hemp oil enriched with
    CBD on cancer cells, pushing the boundaries of the established anti-
    tumor properties of CBD.
-  ETST is developing a variety of nutraceuticals, bioceuticals and dietary
    supplements for health, wellness, sports and alternative medicine, as
    well as natural alternatives to prescription medications, both CBD and
    non-CBD based.
-  ETST has developed a unique menopause and perimenopause formula for
    aging women known as ProgesteBeauty(TM), and the company is currently in
    the process of opening the first retail location for their wholly-owned
    Nutrition Empire, Inc. subsidiary in an upscale area of Coral Gables,
    Florida. The retail footprint will help support product roll outs and
    the company will also be working to dovetail their overall commercial
    presence with key strategic partners and third party resellers who
    already control chunks of the nutritional and supplement markets.
-  ETST has secured a lease for their initial retail location, which is
    situated right on the edge of the University of Miami campus, on the
    first floor of a luxury apartment complex, that stipulates no other
    nutrition or supplement store will be located within a three-mile
    radius. This will also be the first retail store in all of Dade County
    where consumers can walk right in and buy CBD oil over the counter, as
    well as get their hands on ProgesteBeauty, or the company's soon-to-be-
    released, oxygen-based colon cleanser with probiotics (L. rhamnosus and
    L. acidophilus), OxyBiotic(TM).
-  ETST goal is to have around 600 best-in-class health and wellness
    products in-store, as well as a terminal for customers to order products
    for next-day delivery, again emphasizing ready supply as a key brand
    hallmark.


ETST is happy to see that the Cannabis Financial Network has taken notice that ETST is an emerging company delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine. This also includes that fact that ETST looks to help improve the quality of life for Consumers Worldwide through the use of such products. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. To read the coverage and article featured by the Cannabis Financial Network on ETST see below.
Earth Science Tech Brings High Grade CBD To 50 States Via Volume Inventory Model

Cannabis Financial Network / Whitefish, MT / By now nearly everyone has heard of the case of Charlotte Figi, a seven-year-old girl with Dravet Syndrome (a form of severe and intractable epilepsy), who was having as many as 50 seizures a day. In desperation, Charlotte's parents tried everything pharmaceutical science could throw at the problem, even debilitating drugs like barbiturates and benzodiazepines, in an ultimately futile attempt to curb the devastation. The father finally took the leap to try a low-THC (Tetrahydrocannabinol, the psychoactive component), CBD-rich (Cannabidiol) strain of medical marijuana known as Charlotte's Web and since dosing, his daughter has truly thrived, with only two to three seizures per month and a much-improved overall condition. A groundbreaking clinical trial is coming up to study Charlotte's Web in Dravet Syndrome at the University of Colorado and this study's results could provide a real boost to the CBD, as well as broader, medical marijuana markets.

The CBD market in particular has been growing by leaps and bounds in recent years, with heavy-hitters like GW Pharmaceuticals (GWPH) already seeing good traction on their Multiple Sclerosis treatment, Sativex(r), which clearly benefits a great deal from CBD's increasingly apparent pain-relieving, anti-inflammatory, and immunodulatory effects. Smaller players like CannaVEST Corp. (CANV) are finding the market wide open too and CannaVEST has managed to establish a considerable CBD supply business, while also working on a range of industrial hemp-derived CBD nutraceuticals. Industrial hemp is widely known for its low THC levels and comparatively higher levels of CBD, making it an ideal source for developing health and wellness products intended to treat a whole host of conditions, from chronic pain and epilepsy, to diabetes. Even various neurological disorders like ADHD and Parkinson's disease are among the immediate prospects for CBD-rich offerings, according to Project CBD.

CBD has even been shown to promote nutritional health in aging people, acting as an antioxidant and neuroprotectant, superbly suited to age-related inflammatory and autoimmune diseases. Pair the 10,000-plus Baby Boomers retiring per day (Pew Research) and Research and Markets' latest report on the U.S. nutraceutical market indicating a projected 6% CAGR through 2017, as the space swells to some $75.3B or more, and you get a perfect storm for CBD nutraceuticals.

Ready-Supply Inventory Model, Maximum Distribution Potential

One of the more compelling plays in the space today is Earth Science Tech, Inc. (ETST), which recently received its first two shipments of non-psychoactive, food-grade, CBD-enriched hemp oil, which is completely legal in 50 states and over 40 countries worldwide (as per U.S. Hemp Foods specifications). With over 50 liters from their first two shipments, an initial order already out the door to an outlet in Fort Lauderdale and management working hard to drum up additional supply lines, Earth Science Tech is rapidly moving towards widespread commercialization while setting themselves up to be a high-volume throughput channel for high-grade CBD. Perhaps more importantly, management is steadfastly committed to genuinely helping consumers get the best nutrition and dosing information possible, as well as creating shareholder upside. This was clearly demonstrated by the CEO in a recent video interview with leading cannabis investment news source, CannabisFN, when he said a salary won't be pursued until he knows the company is doing well.

CannabisFN Executive Interview | Earth Science Tech (ETST) from TDM Financial on Vimeo.

Earth Science Tech has already begun making their CBD products available online in half-ounce, ounce and two ounce bottles, and has made sizeable investments into their high-volume inventory model, with hundreds of thousands of dollars already outlaid and ambitions to fill persistent supply constraints in the CBD market via a steady stream of readily available product. Earth Science Tech has even funded assistant dean of the University of Central Oklahoma's College of Mathematics and Science, Wei R. Chen, Ph.D., with a $10k grant to study the anti-tumor effects of the such hemp oil enriched with CBD on cancer cells, pushing the boundaries of the established anti-tumor properties of CBD. Dr. Chen brings an impressive track record of over two decades in cancer research to the project as its lead and has noted that the project may result in a new understanding of the potential applications of this non-toxic and largely beneficial natural product.

Developing Nutraceutical Portfolio, Retail Footprint

Beyond raw CBD enriched hemp oil, Earth Science Tech is seeking to develop a variety of nutraceuticals, bioceuticals and dietary supplements for health, wellness, sports and alternative medicine, as well as natural alternatives to prescription medications, both CBD and non-CBD based. This is the same model employed to great success by companies like LifeVantage Corp. (LFVN), which notably cropped out into sports nutrition recently, extending their reach from a strong base in nutraceutical dietary supplements.

Earth Science Tech has developed a unique menopause and perimenopause formula for aging women known as ProgesteBeauty(TM), and the company is currently in the process of opening the first retail location for their wholly-owned Nutrition Empire, Inc. subsidiary in an upscale area of Coral Gables, Florida. The retail footprint will help support product roll outs and the company will also be working to dovetail their overall commercial presence with key strategic partners and third party resellers who already control chunks of the nutritional and supplement markets. Earth Science Tech has secured a lease for their initial retail location, which is situated right on the edge of the University of Miami campus, on the first floor of a luxury apartment complex, that stipulates no other nutrition or supplement store will be located within a three-mile radius. The location is right by a 24k square foot gourmet grocery store as well, in a premier shopping district with loads of foot traffic. This will also be the first retail store in all of Dade County where consumers can walk right in and buy CBD oil over the counter, as well as get their hands on ProgesteBeauty, or the company's soon-to-be-released, oxygen-based colon cleanser with probiotics (L. rhamnosus and L. acidophilus), OxyBiotic(TM). The goal is to have around 600 best-in-class health and wellness products in-store, as well as a terminal for customers to order products for next-day delivery, again emphasizing ready supply as a key brand hallmark.

Spartan Management Leveraging Top Consultants

Unlike many other companies in a similar position, which might tend to bloat the management team with a lot of extraneous personnel in order to try and cover all their bases, ETST has opted to create a lean and mean management team, tapping the best of the best in requisite fields to act as consultants. By maintaining a network of top-quality consultants, the kind of expert formulators responsible for the company's ProgesteBeauty and OxyBiotic formulas, ETST aims to keep management expenses down and yet remain highly competitive in the space.

For More Information Visit Earth Sciences Company Website: http://www.earthsciencetech.com/.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

SOURCE: Emerging Growth LLC

ETST is proud to offer the finest, most natural and consistent High Grade CBD Rich Hemp Oil with no fillers, preservatives or additives. The company's CBD Rich Hemp Oil is made for consumers who want the highest quality natural CBD. ETST High Grade CBD (Cannabidiol) Rich Hemp Oil is natural and formulated using a wide array of cutting-edge technologies such as super critical extraction, isolation, and micron filtration. It is lab tested multiple times during the manufacturing process, from seed to shelf. This also includes being tested for CBD content, other Cannabinoid content, yeast/mold/fungus, and bacteria like E. coli to ensure safety and top quality. Cannabidiol (CBD) is a naturally occurring constituent of the hemp plant (seed, stem and stalk). It is the most abundant non-psychoactive cannabinoid in hemp (cannabis), and is commonly used as a dietary supplement to support general health, immune system support, nervous system and much more. Research shows that many scientists and doctors think the cannabinoids work synergistically to support the whole human endo-cannabinoid system (internal and natural human cannabinoid system). Furthermore, many scientists and doctors believe the endo-cannabinoid system plays a fundamental role in the functioning of many of the major human physiological systems, including the immune and nervous systems.

ETST is capable of supplying and offering its High Grade CBD Rich Hemp Oil in all 50 states and over 40 countries as a nutritional and dietary supplement designed to support overall health and wellness.

ETST invites all interested parties to contact the company directly at info@earthsciencetech.com in regards to securing its All Natural High Grade CBD (Cannabidiol) Rich Hemp Oil for wholesale, resale, private labeling or distribution. ETST is open to forming new strategic partnerships, joint ventures and/or supplying vendors, resellers and third party distribution companies with its High Grade CBD Rich Hemp Oil at wholesale prices in order to better help supply the health and wellness markets on a large scale. The company feels it can grow at a much faster pace by focusing on becoming a large wholesale distributor of its High Grade CBD Rich Hemp Oil and by aligning itself with key strategic partners and third party resellers that are already well diversified in the Health and Wellness markets. ETST's High Grade CBD Rich Hemp Oil is All Natural and derived completely from the federally legal industrial hemp plant. Industrial Hemp (Hemp) is not marijuana and will not get you 'high' and it does not require a medical license of any kind to authorize purchase. Hemp oil contains CBD -- a non-psychoactive compound of the plant. There are millions of hemp oil consumers around the world and this number is rapidly rising with an increasing number of reports and studies showing a variety of benefits of hemp oil. ETST is now offering the availability for the Health and Wellness markets, consumers and its shareholders to try its All Natural High Grade CBD Rich Hemp Oil in small quantities at wholesale prices online at http://www.earthsciencetech.com/cbd-rich-hemp-oil/.

ABOUT ETST: ETST is a unique Biotechnology company focused on delivering cutting edge Nutraceuticals, Bioceuticals and Dietary Supplements designed for excellence in the areas of Health, Wellness, Sports and Alternative Medicine and to improving the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. This may include products such as CBD (Cannabidiol) as a natural constituent of Hemp Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. These products may be in various formulations and delivery systems including (but not limited to) capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders, and whole herbs.

ETST is focused on researching and developing innovative Hemp extracts and to make them accessible Worldwide. ETST plans to be the premier supplier of the highest quality Hemp Oil Enriched with High Grade CBD (Cannabidiol). ETST primary goal is to advance different High Quality Hemp extracts with a broad profile of Cannabinoids and additional natural molecules found in Industrial Hemp and to identify their distinct properties. The company is dedicated in offering its consumers the finest and purest quality All Natural CBD Rich Hemp oil while never compromising on quality. This High Grade CBD (Cannabidiol) Rich Hemp oil is classified as "food based" and therefore perfectly permissible in all 50 states and more than 40 countries. Cannabinoids (Cannabidiol/CBD) are natural constituents of the Hemp plant and CBD is derived from Hemp stalk and seed. Hemp oil is a well-known dietary supplement and the naturally occurring CBD possesses no psychoactive qualities and presents a continuing stream of overwhelming evidence of significant Health and Wellness benefits. With no psychoactive ingredient, CBD is a ready-for-market Hemp-based Nutraceutical. According to scientific and clinical studies, CBD has the potential to help a range of conditions including epilepsy, diabetes, rheumatoid arthritis, chronic pain, alcoholism, schizophrenia, PTSD, antibiotic-resistant infections, and various neurological disorders (Source: National Center for Biotechnology Information http://www.ncbi.nlm.nih.gov). CBD has moreover exhibited Neurogenic and Neuroprotective effects and its anti-cancer properties are currently being investigated at several academic research centers in the United States and abroad. The United States Food and Drug Administration (FDA) currently considers non-THC hemp based cannabinoids, including CBD, to be "food based" and therefore saleable. These new non-psychoactive CBD-rich hemp oil products that ETST has geared up to market and distribute are beyond reproach and available to consumers in all 50 states and in more than 40 countries. CBD (cannabidiol), a naturally occurring constituent of the industrial hemp plant, promotes and supports the nutritional health of aging bodies in particular. Source: US Government Patent #6,630,507 "Cannabinoids as antioxidants and neuroprotectants."

FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE: These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.

FORWARD LOOKING DISCLAIMER: This release contains forward-looking statements that involve risks and uncertainties. Readers are referred to the Securities and Exchange Commission filings filed by the Company on EDGAR at http://www.sec.gov/edgar.shtml, specifically the most recent reports which identify important risk facts that could cause actual results to differ from those contained in the forward-looking statements. The Company undertakes no obligation to review or confirm analysts' expectations or estimates or to publicly release any revisions to any forward-looking statements. The information contained in this press release should not be construed as any indication of the Company's future stock price, its revenues or results of operations.

Embedded Video Available: http://vimeo.com/106424035

Contact:
Earth Science Tech, Inc.
Phone: +1(561) 705-1278

SOURCE: Earth Science Tech, Inc.

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated one thousand six hundred dollars for Earth Science Tech, Inc. news coverage by the Company.  FNMG HOLDS NO SHARES OF Earth Science Tech, Inc.

 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Tuesday, September 23, 2014

RiceBran Technologies Enters the Personal Care and Nutricosmetics Markets with a Series of Newly Developed Rice Bran Based Products

New products developed at Healthy Natural subsidiary capitalize on unique composition of rice bran, rice bran oil and rice bran derivatives to protect and maintain skin health

SCOTTSDALE, Ariz., - (http://www.financialnewsmedia.com News Alert) - RiceBran Technologies (NASDAQ: RIBT) and (RIBTW) (the "Company" or "RBT"), a global leader in the production and marketing of value added products derived from rice bran, today announced completion of the development of a series of new rice bran-based finished products targeting the personal care and nutricosmetics markets. 

In collaboration with new and existing customers, the Company has developed its initial cosmetics and personal care product offerings using rice bran and derivatives produced in its USA Segment plants, as well as rice bran oil manufactured at its Irgovel facility in Pelotas, Brazil.

The new rice bran-based products, which include hand and skin creams, anti-aging serum, exfoliants, moisturizers, and other treatments, were formulated at the Company's Healthy Natural facility in Irving, Texas. Healthy Natural's management team has extensive experience formulating and manufacturing natural products-based cosmetics and personal care products for the retail and direct-to-consumer markets, and has been developing products targeting the personal care and cosmetics markets for more than 20 years. 

These new product offerings will be sold as private label finished products on a business-to-business basis. RiceBran Tehnologies is in active discussions with a number of potential partners to launch its products through a variety of distribution channels and expects the initial products to reach consumers in the fourth quarter of 2014 and the first quarter of 2015.

Mark McKnight, Senior Vice President of Contract Manufacturing at RiceBran Technologies, commented, "During the last decade, the natural products industry has seen nutritional ingredients rich in anti-oxidants and other micronutrients migrate into cosmetics and personal care formulas, creating an emerging "nutricosmetics" marketplace. Rice bran contains many high value ingredients, including gamma oryzanols, ceramides, vitamin E and UV absorbing compounds that help protect and maintain skin health by promoting hydration and elasticity.  We see our newly launched rice bran-based products as a perfect fit for this multi-billion dollar market opportunity."

CEO & President W. John Short commented, "Rice bran has a long history of inclusion in beauty products in Japan and other Asian markets. In fact, one of the greatest compliments a Japanese woman can be given is to be called a "rice bran beauty" or Nuka Bijin. When we made the decision to acquire Healthy Natural, we believed that the addition of superior formulation capabilities would not only further our market penetration in nutritional and functional foods but would also enable us to move into other high growth areas such as the nutricosmetics and personal care markets. With this launch, we are taking a major step forward in that direction. This represents a significant revenue growth opportunity for our Company in 2015 and for many years to come."

RiceBran Technologies is a human food ingredient and animal nutrition company focused on the procurement, bio-refining and marketing of numerous products derived from rice bran. Rice Bran Technologies has proprietary and patented intellectual property that allows us to convert rice bran, one of the world's most underutilized food sources, into a number of highly nutritious human food ingredient and animal nutrition products. Our target markets are human food ingredients and animal nutrition manufacturers and retailers, as well as natural food, functional food and nutraceutical supplement manufacturers and retailers, both domestically and internationally. More information can be found in our filings with the SEC and by visiting our website at www.ricebrantech.com.

Forward-Looking Statements

This release contains forward-looking statements, including, but not limited to, statements about RiceBran Technologies' expectations regarding opportunities in the cosmetics. These statements are made based upon current expectations that are subject to known and unknown risks and uncertainties.  RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information.  Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies' filings with the Securities and Exchange Commission, including its most recent periodic reports. 

Investor Contact

Ascendant Partners, LLC
Fred Sommer
+1-732-410-9810
fred@ascendantpartnersllc.com

SOURCE RiceBran Technologies

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher that disseminates electronic information through multiple online media channels. FNMG's intended purposes are to deliver market updates and news alerts issued from private and publicly trading companies as well as providing coverage and increased awareness for companies that issue press to the public via online newswires. FNMG and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. The companies that are discussed in this release may or may not have approved the statements made in this release. Information in this release is derived from a variety of sources that may or may not include the referenced company's publicly disseminated information. The accuracy or completeness of the information is not warranted and is only as reliable as the sources from which it was obtained. While this information is believed to be reliable, such reliability cannot be guaranteed. FNMG disclaims any and all liability as to the completeness or accuracy of the information contained and any omissions of material fact in this release. This release may contain technical inaccuracies or typographical errors. It is strongly recommended that any purchase or sale decision be discussed with a financial adviser, or a broker-dealer, or a member of any financial regulatory bodies. Investment in the securities of the companies discussed in this release is highly speculative and carries a high degree of risk. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. This release is not without bias, and is considered a conflict of interest if compensation has been received by FNMG for its dissemination. To comply with Section 17(b) of the Securities Act of 1933, FNMG shall always disclose any compensation it has received, or expects to receive in the future, for the dissemination of the information found herein on behalf of one or more of the companies mentioned in this release. For current services performed FNMG has been compensated one thousand six hundred dollars for RiceBran Technologies news coverage by the Company.  FNMG HOLDS NO SHARES OF RiceBran Technologies.

 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.

Friday, September 19, 2014

Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System

The Company Expects to Build and Ship Nine Instrument Systems for Evaluation between Mid-October and Late November. The Company Believes One or More Systems will be Purchased by the Evaluating Laboratories, Impacting Q4 2014 Revenue

SOUTH EASTON, Mass., - (http://www.financialnewsmedia.com News Alert) - Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company") today announced it has received and approved all parts required to build nine high throughput Barozyme HT48 instruments and has begun to manufacture the new PCT-based instrument system. The Company believes the first instrument will be ready for shipment by mid-October and that additional Barozyme instruments will be built and released at a rate of about one per week thereafter.

The bench-top Barozyme HT48 is a first-in-class, high throughput PCT-based instrument. It is capable of processing up to 48 samples simultaneously using the Company's new and proprietary BaroFlex 8-well processing strips. The BaroFlex strips were designed and manufactured to the industry-standard micro-titer plate format, which the Company believes will allow the new Barozyme HT48 system to seamlessly integrate with the automated, standardized, high throughput liquid handling robotic and analytical systems installed in tens of thousands of biological research laboratories worldwide.

Dr. Nathan P. Lawrence, Vice President of Marketing and Sales, said: "the Barozyme HT48 was specifically designed for rapid, high quality enzymatic digestion of proteins, a universally important procedure conducted in thousands of laboratories worldwide. The ability of the Barozyme HT48 to process up to 48 samples simultaneously in a "microplate" format is a major improvement in the ergonomics of sample handling and a key step towards automation of PCT-based biological sample preparation. The new BaroFlex format of disposable sample containers in strips of eight processing wells not only lowers the total cost per sample processed by PCT but improves the sample handling and user experience. Lastly, the Barozyme HT48's flexible computer control was designed with GLP compliance in mind to meet specific demands of biopharmaceutical quality control and clinical proteomics."

Mr. Richard T. Schumacher, President and CEO, said: "With a growing list of potential customers and strategic partners interested in evaluating the Barozyme HT48, our number one priority over the past three months has been to focus on the manufacture of the initial build of instrument systems, with a target of having commercial-grade instruments and consumables available for evaluation by this fall. I am pleased to report that we are on schedule to meet that target."

Mr. Schumacher continued: "We gave guidance earlier this year to not expect the sale of Barozyme HT48 instruments in 2014. However, based on discussions with existing customers (such as one who asked to evaluate the Barozyme HT48 ASAP because the number of samples they routinely process by PCT "was exploding") we are changing that guidance. We now believe that the evaluation period required by some existing customers will be shorter than first thought, and that one or more existing customers will ask to purchase the instrument shortly after their evaluation concludes. Based on this and other indications, we continue to believe that the Barozyme HT48 system is a 'game-changer' for PBI."

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. ("PBI") (OTCQB: PBIO) develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Our products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, we have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders. Our primary application development and sales efforts are in the biomarker discovery and forensics areas. Customers also use our products in other areas, such as drug discovery & design, bio-therapeutics characterization, soil & plant biology, vaccine development, histology, and counter-bioterror applications.

Forward Looking Statements

Statements contained in this press release regarding PBI's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to, the risks and uncertainties discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2013, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

For more information about PBI and this press release, please click on the following website link: http://www.pressurebiosciences.com

Please visit us on Facebook, LinkedIn, and Twitter

Investor Contacts: Richard T. Schumacher, President and CEO Nathan P. Lawrence, Vice President, Marketing and Sales (508) 230-1828 (T)

SOURCE Pressure BioSciences, Inc.


FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG was compensated one thousand five hundred dollars for Pressure BioSciences, Inc. news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF Pressure BioSciences, Inc.

 This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not

GenSpera (GNSZ) Wins Summary Judgment in Mhaka Litigation

SAN ANTONIO, Texas, - (http://www.financialnewsmedia.com News Alert) - GenSpera, Inc. (OTCQB: GNSZ), a leader in developing prodrug therapeutics for the treatment of cancer, today announced that the United States District Court for the District of Maryland has granted the company's summary judgment with respect to all pending claims asserted against it by Annastasiah Mhaka.

"We welcome the court's decision and are pleased with the result," said Craig Dionne, GenSpera's CEO. "We believe that our defense against these claims has demonstrated GenSpera's commitment to protecting its technologies and intellectual property portfolio." 

As previously announced in the company's public filings, on March 12, 2012, as a result of certain allegations made by Ms. Mhaka, GenSpera instituted a declaratory judgment action against Annastasiah Mhaka in the United States District Court for the District of Maryland: GenSpera, Inc. v. Mhaka, Civil Action No. MJG-12-772 (D. Md.) seeking a declaratory judgment that Ms. Mhaka should not be added as an inventor to either the US 7,468,354 patent or the US 7,767,648 patent (the '354 patent and '648 patents) (the first of which claims the company's proprietary PSMA-activated lead drug candidate, mipsagargin, and the latter of which claims methods of use of mipsagargin). On May 1, 2013, the Court granted GenSpera's motion for summary judgment and issued a declaratory judgment establishing that Ms. Mhaka should not be added to the two patents under 35 U.S.C. $ 256.

As part of the litigation, Ms. Mhaka made certain counterclaims against GenSpera, along with Drs. Samuel Denmeade and John Isaacs (two of the company's co-founders), based on allegations that she had been wrongly omitted from the '354 patent and '648 patent. On January 2, 2014, Drs. Isaacs and Denmeade moved for summary judgment, and GenSpera joined in the motion. On May 6, 2014, GenSpera moved separately for summary judgment, a motion that Drs. Denmeade and Isaacs joined in part. 

On September 12, 2014, the Court granted GenSpera's motion for summary judgment as well as the motion for summary judgment filed by Drs. Denmeade and Isaacs.  Judgment in favor of GenSpera, Dr. Isaacs, and Dr. Denmeade was entered concurrently. 

About GenSpera

GenSpera's technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a prodrug delivery system that provides for the targeted release of drug candidates within a tumor. Unlike typical chemotherapeutic agents, thapsigargin results in cell death irrespective of the rate of cell division, which may provide an effective approach to kill both fast- and slow-growing cancers. GenSpera's lead drug candidate, mipsagargin, is activated by the enzyme PSMA, which is found at high levels in the vasculature of liver and glioblastoma cancers and in the vasculature of almost all other solid tumors. Mipsagargin is therefore expected to have potential efficacy in a wide variety of tumor types.

Mipsagargin Phase II clinical trials are underway in both hepatocellular carcinoma (liver cancer) and glioblastoma patients (brain cancer).

For more information, please visit the company's website: www.genspera.com or follow us on Twitter @GenSperaNews.

Company presentations are available at: http://www.genspera.com/

Watch the Corporate Video:

http://youtu.be/jULjEul-mBk


Cautionary Statement Regarding Forward Looking Information

This news release may contain forward-looking statements. Investors are cautioned that statements in this press release regarding potential applications of GenSpera's technologies constitute forward-looking statements that involve risks and uncertainties, including, without limitation, risks inherent in the development and commercialization of potential products, uncertainty of clinical trial results or regulatory approvals or clearances, need for future capital, dependence upon collaborators and maintenance of our intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements. Additional information on potential factors that could affect our results and other risks and uncertainties will be detailed from time to time in GenSpera's periodic reports filed with the Securities and Exchange Commission.

CONTACT:                

Company:
Craig Dionne, PhD, CEO
GenSpera, Inc.  +1(210) 479-8112

Investor Relations: 
Steve Gersten
Capital Markets Group
Steve@CapMarketsGroup.com
+1-813-926-8920

Media:
Dawn Van Zant
(800) 665 0411

SOURCE GenSpera, Inc.

FN Media Group LLC (FNMG) owns and operates FinancialNewsMedia.com (FNM) which is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNMG is NOT affiliated in any manner with any company mentioned herein. FNMG and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNMG's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNMG is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNMG was compensated one thousand five hundred dollars for GenSpera, Inc news coverage by a non-affiliated third party.  FNMG HOLDS NO SHARES OF GenSpera, Inc  This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNMG undertakes no obligation to update such statements.